Conversely, inhibiting PARP1 suppresses tumor growth through two mechanisms: inducing ferroptosis by repressing SLC7A11, or triggering pyroptosis via caspase-3-mediated gasdermin E cleavage [73, 76]. Here, PARP1 is linked to neoplasm.